Inventor · disambiguated record
Soren Steffensen
Also filed as: STEFFENSEN SOREN
21 granted patents·12 pending applications·140 citations·filing 2008–2024
95Inventor score
Top patents by PatentIndex Score
33 records- 0197US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 0294US8703135B2Biological materials related to c-MetBESTE GERALD·Filed 2012·Granted Apr 22, 2014·41 cites·26 claims
- 0393US9683045B2Biological materials related to c-MetABLYNX NV·Filed 2014·Granted Jun 20, 2017·17 cites·12 claims
- 0493US9346884B2Biological materials related to c-MetABLYNX NV·Filed 2012·Granted May 24, 2016·15 cites·5 claims
- 0592US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 0692US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 0791US11414481B2Serum albumin bindersABLYNX NV·Filed 2018·Granted Aug 16, 2022·6 cites·22 claims
- 0887US9328174B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2013·Granted May 3, 2016·8 cites·11 claims
- 0985US12006352B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Jun 11, 2024·1 cites·6 claims
- 1085US11787874B2Factor X binders enhancing FX activationNOVO NORDISK AS·Filed 2018·Granted Oct 17, 2023·3 cites·7 claims
- 1185US11414480B2Serum albumin binding immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Aug 16, 2022·6 cites·20 claims
- 1285US8591896B2Chemokine receptor binding polypeptidesBRADLEY MICHELLE·Filed 2011·Granted Nov 26, 2013·6 cites·29 claims
- 1385US2023242620A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2023·Application pending·0 cites
- 1481US11644471B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2013·Granted May 9, 2023·2 cites·9 claims
- 1577US11813307B2Polypeptides binding ADAMTS5, MMP13 and aggrecanMERCK PATENT GMBH·Filed 2018·Granted Nov 14, 2023·2 cites·13 claims
- 1676US11897944B2Immunoglobulin single variable domain (ISVD) capable of binding to serum albuminABLYNX NV·Filed 2018·Granted Feb 13, 2024·1 cites·16 claims
- 1776US11603401B2Aggrecan binding immunoglobulinsABLYNX NV·Filed 2018·Granted Mar 14, 2023·2 cites·13 claims
- 1872US2024294617A1Serum albumin bindersABLYNX NV·Filed 2024·Application pending·0 cites
- 1972US2024425837A1Highly potent isvd compounds capable of substituting for fviii(a)NOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 2071US9688763B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2015·Granted Jun 27, 2017·1 cites·10 claims
- 2171US9127067B2Methods of treatment using chemokine receptor binding polypeptidesBRADLEY MICHELLE·Filed 2013·Granted Sep 8, 2015·1 cites·7 claims
- 2269US12098400B2Highly potent ISVD compounds capable of substituting for FVIII(A)NOVO NORDISK AS·Filed 2023·Granted Sep 24, 2024·0 cites·9 claims
- 2369US2024181006A1Polypeptides binding adamts5, mmp13 and aggrecanMERCK PATENT GMBH·Filed 2023·Application pending·0 cites
- 2469US2023416404A1Factor x binders enhancing fx activationNOVO NORDISK AS·Filed 2023·Application pending·0 cites
- 2566US2018355031A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2018·Application pending·0 cites
- 2666US2023060574A1Serum albumin bindersABLYNX NV·Filed 2022·Application pending·0 cites
- 2765US2023312694A1Aggrecan binding immunoglobulinsABLYNX NV·Filed 2022·Application pending·0 cites
- 2863US2024109965A1Immunoglobulin single variable domains targeting t cell receptorABLYNX NV·Filed 2023·Application pending·0 cites
- 2962US2018009888A9Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsBAUMEISTER JUDITH·Filed 2012·Application pending·0 cites
- 3062US2023050615A1Improved serum albumin binding immunoglobulin single variable domainsABLYNX NV·Filed 2022·Application pending·0 cites
- 3157US10174118B2Nucleic acids encoding chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2015·Granted Jan 8, 2019·0 cites·8 claims
- 3254US11466089B2Chemokine receptor binding polypeptidesABLYNX NV·Filed 2017·Granted Oct 11, 2022·0 cites·10 claims
- 3343US2011282033A1Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptorsGONZALEZ PAJUELO MARIA·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Soren Steffensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →